Two Sigma Investments
EBS icon

Two Sigma Investments’s Emergent Biosolutions EBS Stock Holding History

Two Sigma Investments’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.79M Buy
577,128
+318,628
+123% +$3.3M ﹤0.01% 2016
2025
Q4 		$3.2M Sell
258,500
-2,831
-1% -$30.3K ﹤0.01% 2096
2025
Q3 		$2.3M Sell
261,331
-92,338
-26% -$718K ﹤0.01% 2031
2025
Q2 		$2.26M Sell
353,669
-43,131
-11% -$247K ﹤0.01% 1745
2025
Q1 		$1.93M Sell
396,800
-449,966
-53% -$3.72M ﹤0.01% 1762
2024
Q4 		$8.1M Buy
846,766
+103,574
+14% +$950K 0.02% 853
2024
Q3 		$6.21M Buy
743,192
+296,652
+66% +$2.7M 0.01% 972
2024
Q2 		$3.05M Sell
446,540
-567,030
-56% -$2.44M 0.01% 1274
2024
Q1 		$2.56M Sell
1,013,570
-25,030
-2% -$56.4K 0.01% 1322
2023
Q4 		$2.49M Buy
1,038,600
+2,624
+0.3% +$6.17K 0.01% 1368
2023
Q3 		$3.52M Buy
1,035,976
+334,051
+48% +$1.85M 0.01% 1072
2023
Q2 		$5.16M Buy
701,925
+235,542
+51% +$2.18M 0.01% 920
2023
Q1 		$4.83M Buy
466,383
+248,491
+114% +$3M 0.01% 929
2022
Q4 		$2.57M Buy
+217,892
New +$3.37M 0.01% 1180
2022
Q3 		– Sell
-16,706
Closed -$519K – 2552
2022
Q2 		$519K Sell
16,706
-310,911
-95% -$10.6M ﹤0.01% 1809
2022
Q1 		$13.5M Buy
327,617
+84,657
+35% +$3.73M 0.04% 506
2021
Q4 		$10.6M Buy
+242,960
New +$11M 0.02% 757
2021
Q3 		– Sell
-422,055
Closed -$25.6M – 4352
2021
Q2 		$26.6M Buy
+422,055
New +$27.1M 0.06% 396
2020
Q4 		– Sell
-278,030
Closed -$28.7M – 3427
2020
Q3 		$28.7M Buy
+278,030
New +$30M 0.1% 209
2020
Q2 		– Sell
-8,206
Closed -$475K – 3060
2020
Q1 		$475K Buy
+8,206
New +$473K ﹤0.01% 1972
2018
Q2 		– Sell
-21,520
Closed -$1.13M – 3389
2018
Q1 		$1.13M Buy
21,520
+16,714
+348% +$833K ﹤0.01% 1924
2017
Q4 		$223K Buy
+4,806
New +$202K ﹤0.01% 2874
2017
Q3 		– Sell
-56,240
Closed -$1.91M – 2832
2017
Q2 		$1.91M Buy
+56,240
New +$1.74M 0.01% 1454
2016
Q4 		– Sell
-49,006
Closed -$1.54M – 3190
2016
Q3 		$1.54M Sell
49,006
-95,927
-66% -$2.79M 0.01% 1656
2016
Q2 		$4.08M Buy
144,933
+66,675
+85% +$2.61M 0.02% 857
2016
Q1 		$2.85M Sell
78,258
-136,815
-64% -$4.83M 0.01% 971
2015
Q4 		$8.61M Buy
215,073
+121,037
+129% +$4.22M 0.04% 474
2015
Q3 		$2.68M Sell
94,036
-46,837
-33% -$1.54M 0.01% 733
2015
Q2 		$4.64M Buy
140,873
+10,250
+8% +$318K 0.02% 755
2015
Q1 		$3.76M Buy
130,623
+45,742
+54% +$1.31M 0.02% 844
2014
Q4 		$2.31M Buy
+84,881
New +$2.02M 0.01% 971
2014
Q2 		– Sell
-241,418
Closed -$6.1M – 2188
2014
Q1 		$6.1M Buy
241,418
+154,309
+177% +$3.9M 0.03% 557
2013
Q4 		$2M Buy
87,109
+44,966
+107% +$938K 0.01% 995
2013
Q3 		$803K Sell
42,143
-38,873
-48% -$694K 0.01% 1109
2013
Q2 		$1.17M Buy
+81,016
New +$1.17M 0.01% 1072

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Two Sigma Investments's EBS Position: Q1 2026 in Review

Two Sigma Investments increased its Emergent Biosolutions (EBS) stake by 123% in Q1 2026, buying an estimated $3.3M and bringing the position to 577,128 shares worth $4.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2016.

Two Sigma Investments first reported a position in EBS in Q2 2013 and has held it in 35 quarters since. The position peaked at $28.7M in Q3 2020. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Two Sigma Investments held 577,128 shares of Emergent Biosolutions worth $4.79M as of Q1 2026.
  • Two Sigma Investments bought 318,628 Emergent Biosolutions shares in Q1 2026, an estimated $3.3M.
  • Emergent Biosolutions made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2016 holding.
  • Two Sigma Investments first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 35 quarters since.
  • Two Sigma Investments's Emergent Biosolutions position peaked at $28.7M in Q3 2020.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.